UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 284

Sortiert nach

Immune System Disorder and Cancer-Associated Cachexia

Cancers, 2024-05, Vol.16 (9), p.1709

2024

Volltextzugriff (PDF)

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Journal of clinical oncology, 2019-02, Vol.37 (4), p.278-285

2019

Volltextzugriff (PDF)

Phase II Study of Efficacy and Safety of Bevacizumab in Combination With Chemotherapy or Erlotinib Compared With Chemotherapy Alone for Treatment of Recurrent or Refractory Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4743-4750

2007

Volltextzugriff (PDF)

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors

Journal of clinical oncology, 2011-03, Vol.29 (7), p.909-916

2011

Volltextzugriff (PDF)

Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3284-3289

2009

Volltextzugriff (PDF)

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer

Clinical cancer research, 2012-06, Vol.18 (11), p.3163-3169

2012

Volltextzugriff (PDF)

Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer

Annals of surgical oncology, 2019-11, Vol.26 (12), p.3807-3808

2019

Volltextzugriff (PDF)

The relationship between weight gain during chemotherapy and outcomes in patients with advanced non‐small cell lung cancer

Journal of cachexia, sarcopenia and muscle, 2024-06, Vol.15 (3), p.1030-1040

2024

Volltextzugriff (PDF)

Mortality burden of pre‐treatment weight loss in patients with non‐small‐cell lung cancer: A systematic literature review and meta‐analysis

Journal of cachexia, sarcopenia and muscle, 2024-08, Vol.15 (4), p.1226-1239

2024

Volltextzugriff (PDF)

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5407-5415

2008

Volltextzugriff (PDF)

Clinicopathologic Features of Advanced Squamous NSCLC

Journal of thoracic oncology, 2016-09, Vol.11 (9), p.1411-1422

2016

Volltextzugriff (PDF)

Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer

Journal of clinical oncology, 2004-08, Vol.22 (16), p.3238-3247

2004

Volltextzugriff (PDF)

Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy

Cancers, 2021-03, Vol.13 (6), p.1426

2021

Volltextzugriff (PDF)

The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

BMC cancer, 2018-03, Vol.18 (1), p.310-310, Article 310

2018

Volltextzugriff (PDF)

Treatment of advanced squamous cell carcinoma of the lung: a review

Translational lung cancer research, 2015-10, Vol.4 (5), p.524-532

2015

Volltextzugriff (PDF)

Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

Journal of thoracic oncology, 2013-09, Vol.8 (9), p.1121-1127

2013

Volltextzugriff (PDF)

Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis

Current medical research and opinion, 2020-09, Vol.36 (9), p.1497-1505

2020

Volltextzugriff (PDF)

Theoretical and Practical Implications of Treating Cachexia in Advanced Lung Cancer Patients

Cancers, 2019-10, Vol.11 (11), p.1619

2019

Volltextzugriff (PDF)

Phase II Trial of Cetuximab in Patients With Previously Treated Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2006-11, Vol.24 (33), p.5253-5258

2006

Volltextzugriff (PDF)

An Open-Label, Phase II Study of the Polo-like Kinase-1 (Plk-1) Inhibitor, BI 2536, in Patients with Relapsed Small Cell Lung Cancer (SCLC)

Lung cancer (Amsterdam, Netherlands), 2017-02, Vol.104, p.126-130

2017

Volltextzugriff (PDF)

Implications of key trials in advanced nonsmall cell lung cancer

Cancer, 2010-03, Vol.116 (5), p.1155-1164

Bonomi, Philip D.

2010

Volltextzugriff (PDF)

Selecting Patients for Treatment with Epidermal Growth Factor Tyrosine Kinase Inhibitors

Clinical cancer research, 2007-08, Vol.13 (15), p.4606s-4612s

2007

Volltextzugriff (PDF)

The mortality burden of cachexia or weight loss in patients with colorectal or pancreatic cancer: A systematic literature review

Journal of cachexia, sarcopenia and muscle, 2024-08

2024

Volltextzugriff (PDF)

Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer

Seminars in oncology, 2002-02, Vol.29 (1), p.78-86

Bonomi, Philip

2002

Volltextzugriff (PDF)

1 – 25 von 284

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(265)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(139)
Science & Technology
(138)
Life Sciences & Biomedicine
(136)
Oncology
(111)
Female
(78)
Lung Neoplasms - Drug Therapy
(75)
Male
(73)
Middle Aged
(73)
Aged
(71)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(66)
Biological And Medical Sciences
(61)
Medical Sciences
(61)
Adult
(58)
Lung Neoplasms - Pathology
(53)
Carcinoma, Non-Small-Cell Lung - Pathology
(45)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(40)
Neoplasm Staging
(39)
Pneumology
(39)
Tumors Of The Respiratory System And Mediastinum
(38)
Respiratory System
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(76)
Journal Of Thoracic Oncology
(30)
Lung Cancer
(17)
Cancer Research
(11)
Seminars In Oncology
(11)
Cancer
(8)
Clinical Cancer Research
(8)
Chest
(7)
American Journal Of Clinical Oncology
(6)
Clinical Lung Cancer
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immune System Disorder and Cancer-Associated Cachexia

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Phase II Study of Efficacy and Safety of Bevacizumab in Combination With Chemotherapy or Erlotinib Compared With Chemotherapy Alone for Treatment of Recurrent or Refractory Non–Small-Cell Lung Cancer

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors

Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer

Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer

The relationship between weight gain during chemotherapy and outcomes in patients with advanced non‐small cell lung cancer

Mortality burden of pre‐treatment weight loss in patients with non‐small‐cell lung cancer: A systematic literature review and meta‐analysis

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Clinicopathologic Features of Advanced Squamous NSCLC

Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer

Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy

The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

Treatment of advanced squamous cell carcinoma of the lung: a review

Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis

Theoretical and Practical Implications of Treating Cachexia in Advanced Lung Cancer Patients

Phase II Trial of Cetuximab in Patients With Previously Treated Non–Small-Cell Lung Cancer

An Open-Label, Phase II Study of the Polo-like Kinase-1 (Plk-1) Inhibitor, BI 2536, in Patients with Relapsed Small Cell Lung Cancer (SCLC)

Implications of key trials in advanced nonsmall cell lung cancer

Selecting Patients for Treatment with Epidermal Growth Factor Tyrosine Kinase Inhibitors

The mortality burden of cachexia or weight loss in patients with colorectal or pancreatic cancer: A systematic literature review

Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer

Suchergebnisse filtern